Abstract: The invention relates to a microorganism, of the order of lactic acid bacteria or analog, fragment, derivative, mutant or combination thereof. Said microorganism, or analog, fragment, derivative, mutants or combinations thereof can be co-aggregated with at least Staphylococcus aureus or Pseudomonas aeruginosa.
Type:
Grant
Filed:
May 7, 2012
Date of Patent:
March 7, 2017
Assignee:
ORGANOBALANCE MEDICAL AG
Inventors:
Christine Lang, Andreas Raab, Patrick Golletz
Abstract: The invention describes a microorganism of the order of lactic acid bacteria or an analog, fragment, derivative, mutant or combination thereof, wherein the microorganism, or analog, fragment, derivative, mutant or combination thereof can coaggregate with Streptococcus pyogenes.
Type:
Grant
Filed:
May 16, 2012
Date of Patent:
April 12, 2016
Assignee:
ORGANOBALANCE MEDICAL AG
Inventors:
Christine Lang, Andreas Raab, Natalia Bolotina
Abstract: The invention relates to a microorganism, of the order of lactic acid bacteria or analog, fragment, derivative, mutant or combination thereof. Said microorganism, or analog, fragment, derivative, mutants or combinations thereof can be co-aggregated with at least Staphylococcus aureus or Pseudomonas aeruginosa.
Type:
Application
Filed:
May 7, 2012
Publication date:
July 3, 2014
Applicant:
ORGANOBALANCE MEDICAL AG
Inventors:
Christine Lang, Andreas Raab, Patrick Golletz
Abstract: The invention describes a microorganism of the order of lactic acid bacteria or an analogue, fragment, derivative, mutant or combination thereof, wherein the microorganism, or analogue, fragment, derivative, mutant or combination thereof can coaggregate with Streptococcus pyogenes.
Type:
Application
Filed:
May 16, 2012
Publication date:
March 6, 2014
Applicant:
ORGANOBALANCE MEDICAL AG
Inventors:
Christine Lang, Andreas Raab, Natalia Bolotina